SEC Form D private-offering filing
Double Blind Bio Inc.
A new SEC Form D private-offering notice from San Francisco, CA, a $5,619,999 filer-stated offering target in Biotech. The source filing is one click away.
AI agents that automate clinical trial operations, connecting sponsors, sites, and data to speed up trial activation and execution.
Filed 2025-12-29Filed to raise $5,619,999First money in 2025-12-10Raised so far $5,619,999HQ (as filed) San Francisco, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified doubleblindbio.co↗Named in the filing 2 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.